Olympus Innovation Ventures — Full Portfolio
7 tracked investments · listed companies and verified rows first
Alimetry develops the Gastric Alimetry system, a non-invasive body surface gastric mapping device that provides objective diagnostics for patients with chronic gastrointestinal symptoms.
AI & Machine LearningDigital HealthHealthtechMedical DevicesAuckland, NZ
Greg O'Grady(Founder)inArmen Gharibans(Founder)inKaren O'Regan(CBO)inCraig Shannon(CTO)inChristie Dunwoodie(CFO)inChristopher Andrews(CMO)
Co-investorsBooster Innovation FundCerity Partners VenturesGD1MatūMovacIcehouse Ventures+1 more
BioProtect develops a balloon spacer device for brachytherapy procedures, used to create spacing during cancer radiation treatment.
BiotechHealthtechMedical Devices
Itay Barnea(Chief Executive Officer)inDerek Webster(Chief Commercial Officer)inLee Adler(Chief Operating Officer)inShahar Shaked(Chief Financial Officer)inDafna Carmi-Yinon(Chief Product and Clinical Officer)in
Co-investorsAlmeda VenturesMVM Life Science PartnersTriventuresPeregrine VenturesXenia Venture Capital
EndoRobotics develops robotic technology that attaches to standard diagnostic endoscopes, adding multi-degree-of-freedom manipulation to turn them into therapeutic platforms for flexible endoscopic surgery.
HealthtechMedical DevicesRobotics
Co-investorsMagna InvestmentPremier Partners
Eximis Surgical develops a minimally invasive specimen removal device for use in abdominal surgery, enabling surgeons to remove surgical specimens through small incisions rather than requiring larger incisions at the end of procedures.
HealthtechMedical DevicesLouisville, US
Kristin Johnson(Manager/Founder)William Gregg(Manager/Founder)inDonna Ford-Serbu(Manager/Founder)
Co-investorsCerity Partners VenturesQuesta Capital
Advanced ManufacturingSunnyvale, US
John N. Irwin III(Executive Officer)Paul Khuri-Yakub(Executive Officer)Amir Tehrani(Executive Officer, Director)
BoardPriscilla Babb(Director)Andre Khoury-Yacoub(Director)Pierre Khuri-Yakub(Director)
Co-investorsS3 Ventures
Neuspera Medical develops an integrated sacral neuromodulation (iSNM) system that implants a smart neurostimulator near the sacral nerve to treat urinary urge incontinence, a symptom of overactive bladder.
BiotechHealthtechMedical DevicesSan Jose, US
Alexander Yeh(Founder)inMilton M. Morris(Executive Officer, Director)inDave Van Meter(Chief Executive Officer)Steve Paul(Chief Commercial Officer)in
Co-investorsAlumni VenturesCerity Partners VenturesForeground CapitalPortfoliaTreo Ventures, LlcWindham Capital Partners+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





















